Loading
A phase 2 trial of Endoscopic resection in Oesophageal squamous cell carcinoma, run by Chinese Academy of Medical Sciences, with a status the registry has not verified recently.
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma is a phase 2 interventional study registered as NCT04275986 by Chinese Academy of Medical Sciences, with 56 participants planned, started 2020-01-20 and due to reach its primary completion in 2024-01. Interventions recorded: Intensity modulated radiotherapy (IMRT), Chemotherapy. Conditions recorded: Esophageal Squamous Cell Carcinoma.
Linked to the technology Endoscopic resection because the registry's title names it ("endoscopic resection") and Oesophageal squamous cell carcinoma among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Endoscopic resection (EMR / ESD), Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Endoscopic resection (EMR / ESD) and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/